3448 results for «2025»
3448 results
Rapid-fire clinical cases: Session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 case submissions in this session: quadricuspid aortic valve with pure regurgitation treated with Evolut PRO, complex high-risk patient with severe aortic regurgitation and extra-large anatomy, snare-assisted TAVI in case of calcified sinotubular junction, and more!
Rapid-fire abstracts: session 2
27 Nov 2022 – From PCR London Valves 2022
Take advantage of this PCR LV 2022 session to discover more abstracts and learn more about how to predict TAVI bicuspid aortic valve re-access, or right ventricle-pulmonary artery coupling in patients with severe aortic stenosis, among others.
TAVI is a mature procedure: implications for lifelong management of young and old patients
27 Nov 2022 – From PCR London Valves 2022
Take a look at these presentations to learn more about TAVI implications for lifelong management, to understand what is happening in the field of aortic valve intervention and to appreciate the evidence governing the application of this procedure in the lifetime journey of patients with aortic...
Hot TAVI topics - Cerebral embolic protection
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...
Primary mitral regurgitation: treatment options when the anatomy is simple
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.
Transfemoral TAVI access using intravascular lithotripsy in patients with challenging peripheral vascular disease
28 Nov 2022 – From PCR London Valves 2022
Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.
Contemporary best clinical practice for TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.
Clinical update and best practices for optimal large bore management with the MANTA closure device
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.
Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...
TAVI: new devices and procedural refinements
27 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to TAVI new devices and procedural refinements to learn more about Meril's Myval transcatheter heart valve, the newest EVOLUT-FX self-expanding supra-annular valve, the OctaAlign technique with the novel Myval octacor transcatheter heart valve, and more!
TAVI challenges: session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.
TAVI: Late-Breaking Trials and Innovations
27 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!
TMVR challenges
27 Nov 2022 – From PCR London Valves 2022
Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!
Clinical outcomes after TAVI: Session 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about clinical outcomes after TAVI thanks to a selection of abstracts submitted during PCR LV 2022: definition of transcatheter heart valve orientation in bicuspid aortic valve with the DA VINCI study, TAVI with latest device iterations in patients with very...
TAVI complications: Session 2
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover how to face various TAVI complications thanks to a selection of cases presented during PCR LV 2022: percutaneous management of annular rupture during TAVR, syncope after transaortic valve replacement, peri-TAVI papillary muscle rupture, and more!
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
Tricuspid interventions
27 Nov 2022 – From PCR London Valves 2022
How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!